Dr Gianmarco Contino

Gianmarco Contino is Associate Professor of Cancer Genomic Medicine and Honorary Consultant at the University of Birmingham. Previously he was a Clinical lecturer at the University of Cambridge and Addenbrooke’s Hospital. He trained as a surgical oncologist and translational scientist in several institutions including the European Institute of Oncology (Milan), Harvard Medical School and Mass General Hospital (Boston), University of Illinois at Chicago and Imperial College (London). In 2019 he joined as a translational oncology lead a Cambridge based start-up, Cambridge Cancer Genomics, developing AI algorithms to improve therapeutic strategies for cancer therapies. 

His research focuses on cancer genomic of Barrett’s oesophagus and oesophageal adenocarcinoma. He published extensively on molecular biology and cancer genomics of Pancreatic and Oesophageal Adenocarcinoma. His research has been supported by American Italian Cancer Foundation, the Associazione Italiana per la Ricerca sul Cancro, Fondazione Umberto Veronesi, the National Institute for Health Research and the Imperial College NHS foundation.

Gianmarco joined the VHI in 2016 with the aim to investigate the epistemological and ethical questions related to early diagnosis of cancer. He has an interest in defining a theoretical framework that reconciles the intrinsic uncertainty of measuring complex biological processes with the expectation that scientific progress would provide a key to anticipate the natural history of neoplastic and pre-neoplastic lesions.